Symbol="SNDX"
AssetType="Common Stock"
Name="Syndax Pharmaceuticals Inc"
Description="Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. The company is headquartered in Waltham, Massachusetts."
CIK="1395937"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3, WALTHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1397072000"
EBITDA="-160888992"
PERatio="None"
PEGRatio="0"
BookValue="6.36"
DividendPerShare="0"
DividendYield="0"
EPS="-2.32"
RevenuePerShareTTM="2.173"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.228"
ReturnOnEquityTTM="-0.379"
RevenueTTM="126576000"
GrossProfitTTM="139709000"
DilutedEPSTTM="-2.32"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="332.97"
AnalystTargetPrice="33.71"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="12.67"
PriceToBookRatio="4.872"
EVToRevenue="10.25"
EVToEBITDA="-119.95"
Beta="1.125"
num_52WeekHigh="29.86"
num_52WeekLow="18.05"
num_50DayMovingAverage="20.92"
num_200DayMovingAverage="22.99"
SharesOutstanding="68821000"
DividendDate="None"
ExDividendDate="None"
symbol="SNDX"
open="20.55"
high="20.80"
low="20.18"
price="20.30"
volume="296096.00"
latest_trading_day="2023-07-07"
previous_close="20.55"
change="-0.25"
change_percent="-1.2165%"
aroon_positive_momentum_days="33"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="33"
Volume_recent_avg="882696"
Change_recent_avg="-0.07"
Delta_recent_avg="0.91"
Variance_recent_avg="0.46"
Change_ratio_recent_avg="-0.34"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="33"
Aroon_momentum_negative="67"
image_negative_thumbnail_id_1="1161"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0195.jpeg"
image_negative_thumbnail_id_2="1163"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0197.jpeg"
image_neutral_thumbnail_id_1="596"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_neutral_thumbnail_id_2="527"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_positive_thumbnail_id_1="997"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0159.jpeg"
image_positive_thumbnail_id_2="994"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0156.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
